Human testing of the first anti-nicotine vaccine has begun, according to
British drugs company Xenova. Medical director John Roberts says the drug could
help people quit because it prevents nicotine acting on the brain and so stops
addiction. Nicotine patches or gum simply substitute inhaled nicotine with a
more benign form. The vaccine will work best for smokers who risk relapsing
after quitting. The vaccine will stop a lapse of will power “sending you back to
the beginning of the craving cycle”, says Roberts.
To continue reading, today with our introductory offers
Advertisement
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
Man destined for Alzheimer's may have been saved by accidental therapy
2
Woman in cancer remission without treatment in highly unusual case
3
A lost ancient script reveals how writing as we know it really began
4
Extinct relative of koalas discovered in Western Australia
5
We have figured out a new way to send messages into the past
6
Hantavirus: Where has the deadly cruise ship outbreak come from?
7
The 50-year quest to create a quantum spin liquid may finally be over
8
Smart underwear detects lactose intolerance by tracking your farts
9
Honey has been used as medicine for centuries – does it really work?
10
The problem of cosmic inflation and how to solve it
